Cav1.1 in malignant hyperthermia

Pathologies of Calcium Channels

Volumn , Issue , 2014, Pages 151-165

  Yarotskyy, Viktor ^a   Dirksen, Robert T ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Dihydropyridine receptor; Excitation contraction coupling; Malignant hyperthermia; Ryanodine receptor

Indexed keywords

EID: 84956819799     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-642-40282-1_8     Document Type: Chapter

References (60)

1. Adams BA, Tanabe T, Mikami A, Numa S, Beam KG (1990) Intramembrane charge movement restored in dysgenic skeletal muscle by injection of dihydropyridine receptor cDNAs. Nature 346:569-572
2. Avila G, Dirksen RT (2000) Functional impact of the ryanodine receptor on the skeletal muscle L-type Ca(2 +) channel. J Gen Physiol 115:467-480
3. Avila G, Dirksen RT (2001) Functional effects of central core disease mutations in the cytoplasmic region of the skeletal muscle ryanodine receptor. J Gen Physiol 118:277-290
4. Bannister RA, Beam KG (2012) Ca(V)1.1: the atypical prototypical voltage-gated Ca(2 +) channel. Biochim Biophys Acta 1828:1587-1597
5. Beard NA, Sakowska MM, Dulhunty AF, Laver DR (2002) Calsequestrin is an inhibitor of skeletal muscle ryanodine receptor calcium release channels. Biophys J 82:310-320
6. Beurg M, Ahern CA, Vallejo P, Conklin MW, Powers PA, Gregg RG, Coronado R (1999) Involvement of the carboxy-terminus region of the dihydropyridine receptor beta1a subunit in excitation-contraction coupling of skeletal muscle. Biophys J 77:2953-2967
7. Block BA, Imagawa T, Campbell KP, Franzini-Armstrong C (1988) Structural evidence for direct interaction between the molecular components of the transverse tubule/sarcoplasmic reticulum junction in skeletal muscle. J Cell Biol 107:2587-2600
8. Canato M, Scorzeto M, Giacomello M, Protasi F, Reggiani C, Stienen GJ (2010) Massive alterations of sarcoplasmic reticulum free calcium in skeletal muscle fibers lacking calsequestrin revealed by a genetically encoded probe. Proc Natl Acad Sci U S A 107:22326-22331
9. Capacchione JF, Muldoon SM (2009) The relationship between exertional heat illness, exertional rhabdomyolysis, and malignant hyperthermia. Anesth Analg 109:1065-1069
10. Carpenter D, Ringrose C, Leo V, Morris A, Robinson RL, Halsall PJ, Hopkins PM, Shaw MA (2009) The role of CACNA1S in predisposition to malignant hyperthermia. BMC Med Genet 10:104
11. Dainese M, Quarta M, Lyfenko AD, Paolini C, Canato M, Reggiani C, Dirksen RT, Protasi F (2009) Anesthetic-and heat-induced sudden death in calsequestrin-1-knockout mice. FASEB J 23:1710-1720
12. Davies A, Kadurin I, Alvarez-Laviada A, Douglas L, Nieto-Rostro M, Bauer CS, Pratt WS, Dolphin AC (2010) The alpha2delta subunits of voltage-gated calcium channels form GPIanchored proteins, a posttranslational modification essential for function. Proc Natl Acad Sci U S A 107:1654-1659
13. Davis M, Brown R, Dickson A, Horton H, James D, Laing N, Marston R, Norgate M, Perlman D, Pollock N, Stowell K (2002) Malignant hyperthermia associated with exercise-induced rhabdomyolysis or congenital abnormalities and a novel RYR1 mutation in New Zealand and Australian pedigrees. Br J Anaesth 88:508-515
14. Dirksen RT (2002) Bi-directional coupling between dihydropyridine receptors and ryanodine receptors. Front Biosci 7:d659-d670
15. Dirksen RT, Avila G (2004) Distinct effects on Ca2 +handling caused by malignant hyperthermia and central core disease mutations in RyR1. Biophys J 87:3193-3204
16. Eltit JM, Bannister RA, Moua O, Altamirano F, Hopkins PM, Pessah IN, Molinski TF, Lopez JR, Beam KG, Allen PD (2012) Malignant hyperthermia susceptibility arising from altered resting coupling between the skeletal muscle L-type Ca2 +channel and the type 1 ryanodine receptor. Proc Natl Acad Sci U S A 109:7923-7928
17. Eltit JM, Li H, Ward CW, Molinski T, Pessah IN, Allen PD, Lopez JR (2011) Orthograde dihydropyridine receptor signal regulates ryanodine receptor passive leak. Proc Natl Acad Sci U S A 108:7046-7051
18. Eltit JM, Yang T, Li H, Molinski TF, Pessah IN, Allen PD, Lopez JR (2010) RyR1-mediated Ca2 +leak and Ca2 +entry determine resting intracellular Ca2 +in skeletal myotubes. J Biol Chem 285:13781-13787
19. Freise D, Held B, Wissenbach U, Pfeifer A, Trost C, Himmerkus N, Schweig U, Freichel M, Biel M, Hofmann F, Hoth M, Flockerzi V (2000) Absence of the gamma subunit of the skeletal muscle dihydropyridine receptor increases L-type Ca2 +currents and alters channel inactivation properties. J Biol Chem 275:14476-14481
20. Gach MP, Cherednichenko G, Haarmann C, Lopez JR, Beam KG, Pessah IN, Franzini-Armstrong C, Allen PD (2008) Alpha2delta1 dihydropyridine receptor subunit is a critical element for excitation-coupled calcium entry but not for formation of tetrads in skeletal myotubes. Biophys J 94:3023-3034
21. Gregg RG, Messing A, Strube C, Beurg M, Moss R, Behan M, Sukhareva M, Haynes S, Powell JA, Coronado R, Powers PA (1996) Absence of the beta subunit (cchb1) of the skeletal muscle dihydropyridine receptor alters expression of the alpha 1 subunit and eliminates excitation-contraction coupling. Proc Natl Acad Sci U S A 93:13961-13966
22. Groom L, Muldoon SM, Tang ZZ, Brandon BW, Bayarsaikhan M, Bina S, Lee H-S, Sambuughin N, Dirksen RT (2011) Identical de novo mutation in the type I ryanodine receptor gene associated with fatal, stress-induced malignant hyperthermia in two unrelated families. Anesthesiology 115:938-945
23. Hopkins PM, Ellis FR, Halsall PJ (1991) Evidence for related myopathies in exertional heat stroke and malignant hyperthermia. Lancet 338:1491-1492
24. Ikemoto N, Yamamoto T (2000) Postulated role of inter-domain interaction within the ryanodine receptor in Ca(2 +) channel regulation. Trends Cardiovasc Med 10:310-316
25. Jurkat-Rott K, McCarthy T, Lehmann-Horn F (2000) Genetics and pathogenesis of malignant hyperthermia. Muscle Nerve 23:4-17
26. Kobayashi S, Bannister ML, Gangopadhyay JP, Hamada T, Parness J, Ikemoto N (2005) Dantrolene stabilizes domain interactions within the ryanodine receptor. J Biol Chem 280:6580-6587
27. Kobayashi S, Yamamoto T, Parness J, Ikemoto N (2004) Antibody probe study of Ca2 +channel regulation by interdomain interaction within the ryanodine receptor. Biochem J 380:561-569
28. Kugler G, Weiss RG, Flucher BE, Grabner M (2004) Structural requirements of the dihydropyridine receptor alpha1S II-III loop for skeletal-type excitation-contraction coupling. J Biol Chem 279:4721-4728
29. Larach MG, Brandom BW, Allen GC, Gronert GA, Lehman EB (2008) Cardiac arrests and deaths associated with malignant hyperthermia in north america from 1987 to 2006: a report from the north american malignant hyperthermia registry of the malignant hyperthermia association of the United States. Anesthesiology 108:603-611
30. Lavezzi WA, Capacchione JF, Muldoon SM, Sambuughin N, Bina S, Steele D, Brandom BW (2013) Case report: death in the emergency department: an unrecognized awake malignant hyperthermia-like reaction in a six-year-old. Anesth Analg 116:420-423
31. Leong P, MacLennan DH (1998) The cytoplasmic loops between domains II and III and domains III and IV in the skeletal muscle dihydropyridine receptor bind to a contiguous site in the skeletal muscle ryanodine receptor. J Biol Chem 273:29958-29964
32. MacLennan DH, Phillips MS (1992) Malignant hyperthermia. Science 256:789-794
33. Monnier N, Procaccio V, Stieglitz P, Lunardi J (1997) Malignant-hyperthermia susceptibility is associated with a mutation of the alpha 1-subunit of the human dihydropyridine-sensitive Ltype voltage-dependent calcium-channel receptor in skeletal muscle. Am J Hum Genet 60:1316-1325
34. Nakai J, Dirksen RT, Nguyen HT, Pessah IN, Beam KG, Allen PD (1996) Enhanced dihydropyridine receptor channel activity in the presence of ryanodine receptor. Nature 380:72-75
35. Nakai J, Tanabe T, Konno T, Adams B, Beam KG (1998) Localization in the II-III loop of the dihydropyridine receptor of a sequence critical for excitation-contraction coupling. J Biol Chem 273:24983-24986
36. Nishio H, Sato T, Fukunishi S, Tamura A, Iwata M, Tsuboi K, Suzuki K (2009) Identification of malignant hyperthermia-susceptible ryanodine receptor type 1 gene (RYR1) mutations in a child who died in a car after exposure to a high environmental temperature. Leg Med (Tokyo) 11:142-143
37. Obermair GJ, Kugler G, Baumgartner S, Tuluc P, Grabner M, Flucher BE (2005) The Ca2 +channel alpha2delta-1 subunit determines Ca2 +current kinetics in skeletal muscle but not targeting of alpha1S or excitation-contraction coupling. J Biol Chem 280:2229-2237
38. Obermair GJ, Tuluc P, Flucher BE (2008) Auxiliary Ca(2 +) channel subunits: lessons learned from muscle. Curr Opin Pharmacol 8:311-318
39. Pirone A, Schredelseker J, Tuluc P, Gravino E, Fortunato G, Flucher BE, Carsana A, Salvatore F, Grabner M (2010) Identification and functional characterization of malignant hyperthermia mutation T1354S in the outer pore of the Cavalpha1S-subunit. Am J Physiol Cell Physiol 299:C1345-C1354
40. Protasi F, Paolini C, Canato M, Reggiani C, Quarta M (2011) Lessons from calsequestrin-1 ablation in vivo: much more than a Ca(2 +) buffer after all. J Muscle Res Cell Motil 32:257-270
41. Protasi F, Paolini C, Dainese M (2009) Calsequestrin-1: a new candidate gene for malignant hyperthermia and exertional/environmental heat stroke. J Physiol 587:3095-3100
42. Rosenberg H, Sambuughin N, Dirksen R (2013) Malignant hyperthermia susceptibility. In: GeneReviews at GeneTests: medical genetics information resource [database online]. Copyright, University of Washington, Seattle, 1997-2013
43. Schredelseker J, Di Biase V, Obermair GJ, Felder ET, Flucher BE, Franzini-Armstrong C, Grabner M (2005) The beta 1a subunit is essential for the assembly of dihydropyridinereceptor arrays in skeletal muscle. Proc Natl Acad Sci U S A 102:17219-17224
44. Stewart SL, Hogan K, Rosenberg H, Fletcher JE (2001) Identification of the Arg1086His mutation in the alpha subunit of the voltage-dependent calcium channel (CACNA1S) in a North American family with malignant hyperthermia. Clin Genet 59:178-184
45. Strube C, Beurg M, Powers PA, Gregg RG, Coronado R (1996) Reduced Ca2 +current, charge movement, and absence of Ca2 +transients in skeletal muscle deficient in dihydropyridine receptor beta 1 subunit. Biophys J 71:2531-2543
46. Takekura H, Bennett L, Tanabe T, Beam KG, Franzini-Armstrong C (1994) Restoration of junctional tetrads in dysgenic myotubes by dihydropyridine receptor cDNA. Biophys J 67:793-803
47. Tanabe T, Beam KG, Adams BA, Niidome T, Numa S (1990) Regions of the skeletal muscle dihydropyridine receptor critical for excitation-contraction coupling. Nature 346:567-569
48. Tanabe T, Beam KG, Powell JA, Numa S (1988) Restoration of excitation-contraction coupling and slow calcium current in dysgenic muscle by dihydropyridine receptor complementary DNA. Nature 336:134-139
49. Tanabe T, Takeshima H, Mikami A, Flockerzi V, Takahashi H, Kangawa K, Kojima M, Matsuo H, Hirose T, Numa S (1987) Primary structure of the receptor for calcium channel blockers from skeletal muscle. Nature 328:313-318
50. Tang ZZ, Yarotskyy V, Wei L, Sobczak K, Nakamori M, Eichinger K, Moxley RT, Dirksen RT, Thornton CA (2012) Muscle weakness in myotonic dystrophy associated with misregulated splicing and altered gating of Ca(V)1.1 calcium channel. Hum Mol Genet 21:1312-1324
51. Tobin JR, Jason DR, Challa VR, Nelson TE, Sambuughin N (2001) Malignant hyperthermia and apparent heat stroke. JAMA 286:168-169
52. Tong J, Oyamada H, Demaurex N, Grinstein S, McCarthy TV, MacLennan DH (1997) Caffeine and halothane sensitivity of intracellular Ca2 +release is altered by 15 calcium release channel (ryanodine receptor) mutations associated with malignant hyperthermia and/or central core disease. J Biol Chem 272:26332-26339
53. Toppin PJ, Chandy TT, Ghanekar A, Kraeva N, Beattie WS, Riazi S (2010) A report of fulminant malignant hyperthermia in a patient with a novel mutation of the CACNA1S gene. Can J Anaesth 57:689-693
54. Tuluc P, Flucher BE (2011) Divergent biophysical properties, gating mechanisms, and possible functions of the two skeletal muscle Ca(V)1.1 calcium channel splice variants. J Muscle Res Cell Motil 32:249-256
55. Tung CC, Lobo PA, Kimlicka L, Van Petegem F (2010) The amino-terminal disease hotspot of ryanodine receptors forms a cytoplasmic vestibule. Nature 468:585-588
56. Van Petegem F (2012) Ryanodine receptors: structure and function. J Biol Chem 287:31624-31632
57. Wappler F, Fiege M, Steinfath M, Agarwal K, Scholz J, Singh S, Matschke J, Schulte Am Esch (2001) Evidence for susceptibility to malignant hyperthermia in patients with exerciseinduced rhabdomyolysis. Anesthesiology 94:95-100
58. Weiss RG, O'Connell KM, Flucher BE, Allen PD, Grabner M, Dirksen RT (2004) Functional analysis of the R1086H malignant hyperthermia mutation in the DHPR reveals an unexpected influence of the III-IV loop on skeletal muscle EC coupling. Am J Physiol Cell Physiol 287:C1094-C1102
59. Yang T, Ta TA, Pessah IN, Allen PD (2003) Functional defects in six ryanodine receptor isoform-1 (RyR1) mutations associated with malignant hyperthermia and their impact on skeletal excitation-contraction coupling. J Biol Chem 278:25722-25730
60. Zhao X, Min CK, Ko JK, Parness J, Kim do H, Weisleder N, Ma J (2010) Increased storeoperated Ca2 +entry in skeletal muscle with reduced calsequestrin-1 expression. Biophys J 99:1556-1564